Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Resolution Assessment of Coronary Plaques in a Global Evolocumab Randomized Study (HUYGENS)

NCT03570697 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT03570697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03570697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Resolution Assessment of Coronary Plaques in a Global Evolocumab Randomized Study (HUYGENS)
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
November 19, 2018
Completion date
January 21, 2021
Enrollment
164 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad)